Clinical Trials Directory

Trials / Conditions / Multiple Myeloma Progression

Multiple Myeloma Progression

10 registered clinical trials studyying Multiple Myeloma Progression — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
NCT07075185
Kelonia Therapeutics, Inc.Phase 1
RecruitingSequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma
NCT07032129
Essen BiotechPhase 1 / Phase 2
RecruitingCHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
NCT06644625
Wake Forest University Health Sciences—
WithdrawnA Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multipl
NCT06411301
Jules Bordet InstitutePhase 1
RecruitingEarly Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma
NCT06485076
University Health Network, TorontoN/A
UnknownRivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma
NCT03428373
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sPhase 2 / Phase 3
UnknownAnti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R MM
NCT03706547
Peng LiuPhase 1
TerminatedTinostamustine Conditioning and Autologous Stem Cell
NCT03687125
Mundipharma-EDO GmbHPhase 1 / Phase 2
UnknownPomalidomide/Cyclophosphamide/Dexamethasone in Relapse Refractory Myeloma: Safety Profile in Mexicans
NCT03601624
Instituto de Seguridad y Servicios Sociales de los Trabajadores del EstadoPhase 2
UnknownCAR-T Re-treatment for Refractory/Relapsed Multiple Myeloma
NCT03672253
Second Affiliated Hospital of Xi'an Jiaotong UniversityPhase 1